Evidence map›Paper›PMID 14514985›Full record

ReviewMolecular neurobiology2003

Collapsin response mediator proteins (CRMPs): involvement in nervous system development and adult neurodegenerative disorders.

Emmanuelle Charrier, Sophie Reibel, Véronique Rogemond, Michèle Aguera, Nicole Thomasset, Jérôme Honnorat

Abstract readReview
PubMed Publisher
In one paragraph

Review in Molecular neurobiology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 124 papers.

0numbers the graph read from it
0cells of the map it votes in
124citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

124 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Case report: AFrontiers in neuroscience · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

64 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Emmanuelle CharrierInstitut National de la Santé et de la Recherche Médicale U 433, Hôpital Neurologique, 59 Bd Pinel, 69003 Lyon, France.
Sophie Reibel
Véronique Rogemond
Michèle Aguera
Nicole Thomasset
Jérôme Honnorat

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The members of the collapsin response mediator protein (CRMP) family-five cytosolic phosphoproteins -are highly expressed throughout brain development. The first member to be cloned, CRMP2, was identified as an intracellular messenger required for the growth cone-collapse induced by semaphorin 3A (Sema3A). A rapidly expanding body of study indicates that the functions of CRMPs are not solely limited to the signaling transduction of the Sema3A guidance cue. They are probably involved in multiple cellular and molecular events involved in apoptosis/proliferation, cell migration, and differentiation. In the adult brain, the expression of CRMPs is dramatically downregulated. However, they remain expressed in structures that retain their capacity for differentiation and plasticity and also in a subpopulation of oligodendrocytes (CRMP2 and CRMP5). Moreover, the expression of CRMPs is altered in neurodegenerative diseases, and these proteins may be of key importance in the physiopathology of the adult nervous system.

Indexed as

Avian ProteinsSemaphorinsAgingAnimalsCarrier ProteinsCollapsin Response Mediator Protein 1HumansIntercellular Signaling Peptides and ProteinsNerve Tissue ProteinsNervous SystemNeurodegenerative DiseasesPhosphoproteinsAvian ProteinsCarrier ProteinsCollapsin Response Mediator Protein 1collapsin response mediator protein-2Dpysl3 protein, ratDPYSL4 protein, humanDpysl4 protein, ratIntercellular Signaling Peptides and ProteinsNerve Tissue ProteinsPhosphoproteinsSemaphorin 3E, chickenSemaphorins

Identifiers

PMID14514985

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.